Lastly, Hashmi et al. report that 11% (n = 16) of 148 DLBCL patients experienced a new episode of VTE between day 0 and day 100 after CD-19 CAR T-cell infusion [14]. Here, CD19 is linked to diffuse large B-cell lymphoma.